1 662 92 EFFECT OF 3-MONTH YOGA ON OXIDATIVE STRESS IN TYPE 2 DIABETES WITH OR WITHOUT COMPLICATIONS: A CONTROLLED CLINICAL TRIAL. OBJECTIVE: TO ASSESS THE EFFECT OF YOGA ON ANTHROPOMETRY, BLOOD PRESSURE, GLYCEMIC CONTROL, AND OXIDATIVE STRESS IN TYPE 2 DIABETIC PATIENTS ON STANDARD CARE IN COMPARISON WITH STANDARD CARE ALONE. RESEARCH DESIGN AND METHODS: THE STUDY INVOLVED 123 PATIENTS STRATIFIED ACCORDING TO GROUPS WITH MICROVASCULAR COMPLICATIONS, MACROVASCULAR COMPLICATIONS, AND PERIPHERAL NEUROPATHY AND WITHOUT COMPLICATIONS AND ASSIGNED TO RECEIVE EITHER STANDARD CARE OR STANDARD CARE ALONG WITH ADDITIONAL YOGA FOR 3 MONTHS. RESULTS: IN COMPARISON WITH STANDARD CARE ALONE, YOGA RESULTED IN SIGNIFICANT REDUCTION IN BMI, GLYCEMIC CONTROL, AND MALONDIALDEHYDE AND INCREASE IN GLUTATHIONE AND VITAMIN C. THERE WERE NO DIFFERENCES IN WAIST CIRCUMFERENCE, WAIST-TO-HIP RATIO, BLOOD PRESSURE, VITAMIN E, OR SUPEROXIDE DISMUTASE IN THE YOGA GROUP AT FOLLOW-UP. CONCLUSIONS: YOGA CAN BE USED AS AN EFFECTIVE THERAPY IN REDUCING OXIDATIVE STRESS IN TYPE 2 DIABETES. YOGA IN ADDITION TO STANDARD CARE HELPS REDUCE BMI AND IMPROVE GLYCEMIC CONTROL IN TYPE 2 DIABETIC PATIENTS. 2011 2 1104 43 EFFECTS OF YOGA VERSUS SHAM YOGA ON OXIDATIVE STRESS, GLYCEMIC STATUS, AND ANTHROPOMETRY IN TYPE 2 DIABETES MELLITUS: A SINGLE-BLINDED RANDOMIZED PILOT STUDY. STUDIES HAVE SHOWN A BENEFICIAL ROLE OF YOGA IN TRE A T I N G TYPE 2 DIABETES MELLITUS. THE PRESENT STUDY PROCEEDS IN THE FIELD BY PROVIDING AN ACTIVE CONTROL. WE AIMED TO EVALUATE THE EFFECT OF 3 MONTHS OF YOGA ON OXIDATIVE STRESS, GLYCEMIC STATUS, AND ANTHROPOMETRY IN TYPE 2 DIABETES MELLITUS. FORTY PARTICIPANTS WERE RANDOMIZED TO RECEIVE EITHER YOGA (N = 20) OR SHAM YOGA (N = 20) AS A CONTROL. YOGA INCLUDED POSTURES AND BREATHING EXERCISES, AND NONAEROBIC STRETCHING EXERCISE COMPRISED THE CONTROL. SIGNIFICANT WITHIN-GROUP DIFFERENCES IN MALONDIALDEHYDE, VITAMIN C, SUPEROXIDE DISMUTASE, FASTING BLOOD GLUCOSE, GLYCOSYLATED HEMOGLOBIN, BODY MASS INDEX, WAIST CIRCUMFERENCE, AND BLOOD PRESSURE WERE EVIDENT IN BOTH GROUPS. YOGA PARTICIPANTS HAD SIGNIFICANTLY GREATER IMPROVEMENT IN REDUCED GLUTATHIONE COMPARED TO CONTROLS. NO SIGNIFICANT DIFFERENCES BETWEEN GROUPS WERE OBSERVED IN ANY OTHER OUTCOME VARIABLES. YOGA AND SHAM YOGA HAD IDENTICAL EFFECTS ON OXIDATIVE STRESS, GLYCEMIC STATUS, AND ANTHROPOMETRY IN TYPE 2 DIABETES MELLITUS. LEVELS OF REDUCED GLUTATHIONE IMPROVED ONLY IN THE YOGA GROUP. THIS RESEARCH NEEDS TO BE CONFIRMED BY LARGER AND SUFFICIENTLY POWERED STUDIES. 2020 3 692 55 EFFECT OF COMMUNITY-BASED YOGA INTERVENTION ON OXIDATIVE STRESS AND GLYCEMIC PARAMETERS IN PREDIABETES: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: TO STUDY THE EFFECTIVENESS OF YOGA INTERVENTION ON OXIDATIVE STRESS, GLYCEMIC STATUS, BLOOD PRESSURE AND ANTHROPOMETRY IN PREDIABETES. DESIGN: RANDOMIZED-CONTROLLED TRIAL. PARTICIPANTS: TWENTY NINE PREDIABETES SUBJECTS AGED 30-75 YEARS. SETTING: YOGA WAS CONDUCTED AT 4 DIFFERENT COMMUNITY DIABETES CLINICS IN MANGALORE, INDIA. INTERVENTIONS: PARTICIPANTS WERE RANDOMIZED TO EITHER 3-MONTH YOGA OR WAIT-LIST CONTROL GROUPS. MAIN OUTCOME MEASURES: MALONDIALDEHYDE, GLUTATHIONE, VITAMIN C, VITAMIN E, SUPEROXIDE DISMUTASE, PLASMA GLUCOSE, GLYCATED HAEMOGLOBIN, BMI, WAIST CIRCUMFERENCE, WAIST-TO-HIP RATIO AND BLOOD PRESSURE. RESULTS: YOGA INTERVENTION RESULTED IN A SIGNIFICANT DECLINE IN MALONDIALDEHYDE (P<0.001), RELATIVE TO THE CONTROL GROUP. IN COMPARISON WITH THE CONTROL, THERE WAS A SIGNIFICANT IMPROVEMENT IN BMI, WAIST CIRCUMFERENCE, SYSTOLIC BLOOD PRESSURE AND FASTING GLUCOSE LEVELS AT FOLLOW-UP. NO SIGNIFICANT IMPROVEMENT IN GLYCATED HAEMOGLOBIN, WAIST-TO-HIP RATIO OR ANY OF THE ANTIOXIDANTS WAS OBSERVED. CONCLUSIONS: YOGA INTERVENTION MAY BE HELPFUL IN CONTROL OF OXIDATIVE STRESS IN PREDIABETES SUBJECTS. YOGA CAN ALSO BE BENEFICIAL IN REDUCTION IN BMI, WAIST CIRCUMFERENCE, SYSTOLIC BLOOD PRESSURE AND FASTING GLUCOSE. EFFECT OF YOGA ON ANTIOXIDANT PARAMETERS WAS NOT EVIDENT IN THIS STUDY. THE FINDINGS OF THIS STUDY NEED TO BE CONFIRMED IN LARGER TRIALS INVOLVING ACTIVE CONTROL GROUPS. 2013 4 810 38 EFFECT OF YOGA ON BLOOD GLUCOSE LEVELS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. INTRODUCTION: IN VIEW OF PEOPLE EMBRACING SEDENTARY LIFE STYLE, AND THE EFFECTIVENESS OF TREATMENT BECOMING LESS, THE ROLE OF REGULAR EXERCISE ESPECIALLY 'YOGA' SEEMS TO BE A BENEFICIAL AND ECONOMICAL ADJUVANT IN THE MANAGEMENT OF THE TYPE 2 DIABETES MELLITUS (T2DM). OBJECTIVES: TO ASSESS THE BENEFICIAL EFFECTS OF YOGA ON BLOOD GLUCOSE LEVELS IN NORMAL AND T2DM VOLUNTEERS. MATERIALS AND METHODS: A PROSPECTIVE CASE-CONTROL STUDY WAS CONDUCTED IN THE DEPARTMENT OF PHYSIOLOGY AND DIABETIC CLINIC OF A TERTIARY CARE TEACHING HOSPITAL OVER PERIOD OF TWO YEARS. THE STUDY SUBJECTS CONSISTED OF 30 MALE DIABETIC PATIENTS ATTENDING DIABETIC CLINIC AND 30 NON-DIABETIC MALE VOLUNTEERS CONSTITUTED CONTROL GROUP. THE PATIENTS IN THE AGE GROUP OF 36 TO 55 YEARS WITH T2DM OF AT LEAST ONE YEAR DURATION AND THOSE ON DIABETIC DIET AND ORAL HYPOGLYCEMIC AGENTS WERE INCLUDED IN THE STUDY GROUP. THE AGE MATCHED HEALTHY MALE VOLUNTEERS WHO HAD COME TO JOIN YOGA TRAINING AT YOGA CENTRE WERE INCLUDED IN THE CONTROL GROUP. ALL THE PARTICIPANTS WERE TRAINED BY YOGA EXPERTS AND SUBJECTED TO REGULAR PRACTICE UNDER SUPERVISION FOR SIX MONTHS. IN ALL THE PARTICIPANTS FASTING (FBS) AND POST-PRANDIAL BLOOD SUGAR (PPBS) WAS ESTIMATED BEFORE, DURING (AT THREE MONTHS) AND AFTER (SIX MONTHS) YOGA TRAINING. PAIRED STUDENT T-TEST WAS USED TO ESTIMATE DIFFERENCE IN MEANS CALCULATED BEFORE AND AFTER YOGA TRAINING IN A SAME GROUP. A P-VALUE OF <0.05 WAS CONSIDERED AS STATISTICALLY SIGNIFICANT. RESULTS: THE DISTRIBUTION OF AGE, MEAN HEIGHT AND MEAN WEIGHT AMONG BOTH THE GROUPS WERE COMPARABLE. THE REDUCTION IN MEAN VALUES OF FBS AND PPBS AT THE END OF SIX MONTHS WAS HIGHLY SIGNIFICANT (P <0.001) IN BOTH THE GROUPS WHEN COMPARED WITH THE MEAN VALUES BEFORE AND DURING (THREE MONTHS) YOGA PRACTICE. THE REDUCTION IN THESE VALUES AT THREE MONTHS DURING YOGA WAS HIGHLY SIGNIFICANT IN T2DM GROUP WHEN COMPARED WITH MEAN VALUES BEFORE YOGA (P <0.001), BUT IT WAS INSIGNIFICANT (P<0.05) IN CONTROL GROUP. CONCLUSION: THE RESULTS OF THE PRESENT STUDY DEMONSTRATED THAT THE YOGA IS EFFECTIVE IN REDUCING THE BLOOD GLUCOSE LEVELS IN PATIENTS WITH T2DM. 2015 5 685 32 EFFECT OF AN INTEGRATED NATUROPATHY AND YOGA PROGRAM ON LONG-TERM GLYCEMIC CONTROL IN TYPE 2 DIABETES MELLITUS PATIENTS: A PROSPECTIVE COHORT STUDY. AIM: LIFESTYLE IS AN IMPORTANT RISK FACTOR FOR INCREASING THE PREVALENCE OF DIABETES IN THE INDIAN POPULATION. IN THIS STUDY, WE EVALUATE THE EFFECTS OF NATUROPATHY TREATMENT, SALT-RESTRICTED LOW-CALORIE DIETS, AND YOGA IN LONG-TERM GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. METHODS: IN THIS PROSPECTIVE, LONGITUDINAL, TWO-ARM COHORT STUDY, PATIENTS WITH TYPE 2 DIABETES MELLITUS REFERRED FROM A TERTIARY CARE CENTER UNDERGOING A 3-MONTH RESIDENTIAL NATUROPATHY TREATMENT WERE COMPARED WITH THOSE UNDERGOING ONLY CONVENTIONAL MANAGEMENT ON GLYCEMIC CONTROL. BOTH FASTING AND POSTPRANDIAL BLOOD GLUCOSE (PPBG) LEVELS WERE ASSESSED AT BASELINE, 3 MONTHS FOLLOWING INTERVENTION, AT 6 MONTHS, AND 12 MONTHS FROM THE STUDY START. DATA WERE ANALYZED USING REPEATED-MEASURES ANOVA WITH POST HOC BONFERRONI CORRECTION. RESULTS: NATUROPATHY AND YOGA INTERVENTION SIGNIFICANTLY REDUCED PPBG LEVELS (P < 0.001), GLYCATED HEMOGLOBIN LEVELS (P < 0.001), AND REDUCED REQUIREMENT FOR ANTIDIABETIC MEDICATIONS (P < 0.008) IN THE INTERVENTION GROUP COMPARED TO CONTROLS. THE EFFECTS WERE MORE PROFOUND IMMEDIATELY FOLLOWING INTERVENTION AND LASTED UP TO 6 MONTHS FROM THE START OF THE STUDY. CONCLUSION: THE RESULTS SUGGEST BENEFIT WITH AN INTENSIVE RESIDENTIAL NATUROPATHY-BASED LIFESTYLE INTERVENTION PROGRAM. RANDOMIZED CONTROLLED TRIALS ARE NEEDED TO FURTHER VALIDATE THE FINDINGS. 2020 6 247 42 A YOGA INTERVENTION FOR TYPE 2 DIABETES RISK REDUCTION: A PILOT RANDOMIZED CONTROLLED TRIAL. BACKGROUND: TYPE 2 DIABETES IS A MAJOR HEALTH PROBLEM IN MANY COUNTRIES INCLUDING INDIA. YOGA MAY BE AN EFFECTIVE TYPE 2 DIABETES PREVENTION STRATEGY IN INDIA, PARTICULARLY GIVEN ITS CULTURAL FAMILIARITY. METHODS: THIS WAS A PARALLEL, RANDOMIZED CONTROLLED PILOT STUDY TO COLLECT FEASIBILITY AND PRELIMINARY EFFICACY DATA ON YOGA FOR DIABETES RISK FACTORS AMONG PEOPLE AT HIGH RISK OF DIABETES. PRIMARY OUTCOMES INCLUDED: CHANGES IN BMI, WAIST CIRCUMFERENCE, FASTING BLOOD GLUCOSE, POSTPRANDIAL BLOOD GLUCOSE, INSULIN, INSULIN RESISTANCE, BLOOD PRESSURE, AND CHOLESTEROL. WE ALSO LOOKED AT MEASURES OF PSYCHOLOGICAL WELL-BEING INCLUDING CHANGES IN DEPRESSION, ANXIETY, POSITIVE AND NEGATIVE AFFECT AND PERCEIVED STRESS. FORTY-ONE PARTICIPANTS WITH ELEVATED FASTING BLOOD GLUCOSE IN BANGALORE, INDIA WERE RANDOMIZED TO EITHER YOGA (N = 21) OR A WALKING CONTROL (N = 20). PARTICIPANTS WERE ASKED TO EITHER ATTEND YOGA CLASSES OR COMPLETE MONITORED WALKING 3-6 DAYS PER WEEK FOR EIGHT WEEKS. RANDOMIZATION AND ALLOCATION WAS PERFORMED USING COMPUTER-GENERATED RANDOM NUMBERS AND GROUP ASSIGNMENTS DELIVERED IN SEALED, OPAQUE ENVELOPES GENERATED BY OFF-SITE STUDY STAFF. DATA WERE ANALYZED BASED ON INTENTION TO TREAT. RESULTS: THIS STUDY WAS FEASIBLE IN TERMS OF RECRUITMENT, RETENTION AND ADHERENCE. IN ADDITION, YOGA PARTICIPANTS HAD SIGNIFICANTLY GREATER REDUCTIONS IN WEIGHT, WAIST CIRCUMFERENCE AND BMI VERSUS CONTROL (WEIGHT -0.8 +/- 2.1 VS. 1.4 +/- 3.6, P = 0.02; WAIST CIRCUMFERENCE -4.2 +/- 4.8 VS. 0.7 +/- 4.2, P < 0.01; BMI -0.2 +/- 0.8 VS. 0.6 +/- 1.6, P = 0.05). THERE WERE NO BETWEEN GROUP DIFFERENCES IN FASTING BLOOD GLUCOSE, POSTPRANDIAL BLOOD GLUCOSE, INSULIN RESISTANCE OR ANY OTHER FACTORS RELATED TO DIABETES RISK OR PSYCHOLOGICAL WELL-BEING. THERE WERE SIGNIFICANT REDUCTIONS IN SYSTOLIC AND DIASTOLIC BLOOD PRESSURE, TOTAL CHOLESTEROL, ANXIETY, DEPRESSION, NEGATIVE AFFECT AND PERCEIVED STRESS IN BOTH THE YOGA INTERVENTION AND WALKING CONTROL OVER THE COURSE OF THE STUDY. CONCLUSION: AMONG INDIANS WITH ELEVATED FASTING BLOOD GLUCOSE, WE FOUND THAT PARTICIPATION IN AN 8-WEEK YOGA INTERVENTION WAS FEASIBLE AND RESULTED IN GREATER WEIGHT LOSS AND REDUCTION IN WAIST CIRCUMFERENCE WHEN COMPARED TO A WALKING CONTROL. YOGA OFFERS A PROMISING LIFESTYLE INTERVENTION FOR DECREASING WEIGHT-RELATED TYPE 2 DIABETES RISK FACTORS AND POTENTIALLY INCREASING PSYCHOLOGICAL WELL-BEING. TRIAL REGISTRATION: CLINICALTRIALS.GOV IDENTIFIED NCT00090506. 2014 7 1303 33 HATHA YOGA PRACTICE FOR TYPE 2 DIABETES MELLITUS PATIENTS: A PILOT STUDY. OBJECTIVE: THIS STUDY WAS CONDUCTED TO EXAMINE THE IMPACT OF HATHA YOGA ON GLYCEMIC CONTROL, PSYCHOLOGICAL AND PHYSIOLOGICAL STRESS, AND SELF-CARE FOR INDIVIDUALS WITH TYPE 2 DIABETES MELLITUS (T2DM). METHODS: TEN SEDENTARY INDIVIDUALS WITH T2DM WHO WERE NON-INSULIN DEPENDENT, FREE OF DIABETES-RELATED COMPLICATIONS, AND HAD NO PREVIOUS YOGA EXPERIENCE COMPLETED THERAPEUTIC YOGA CLASSES FOR 6 WEEKS, 3 TIMES PER WEEK . GLYCEMIC CONTROL MEASURES INCLUDED FASTING BLOOD GLUCOSE, GLYCATED HEMOGLOBIN, AND FASTING INSULIN. THE STATE-TRAIT ANXIETY INVENTORY, PERCEIVED STRESS SCALE, AND SALIVARY CORTISOL WERE USED TO ASSESS LEVELS OF STRESS, AND THE SUMMARY OF DIABETES SELF-CARE ACTIVITIES QUESTIONNAIRE WAS USED TO ASSESS REGIMEN ADHERENCE. RESULTS: NO SIGNIFICANT CHANGES IN GLUCOSE CONTROL OR PHYSIOLOGICAL STRESS WERE FOUND; HOWEVER, SIGNIFICANT CHANGES IN PERCEIVED STRESS, STATE ANXIETY, AND SELF-CARE BEHAVIORS WERE DETECTED. CONCLUSIONS: PRELIMINARY FINDINGS SUPPORT FURTHER INVESTIGATION OF THE BENEFITS OF HATHA YOGA AS A COMPLEMENTARY THERAPY FOR THOSE WITH T2DM. 2013 8 959 32 EFFECTS OF A YOGA INTERVENTION ON LIPID PROFILES OF DIABETES PATIENTS WITH DYSLIPIDEMIA. OBJECTIVE: THE PRESENT STUDY WAS CONDUCTED TO ASSESS THE EFFECTIVENESS OF YOGA IN THE MANAGEMENT OF DYSLIPIDEMIA IN PATIENTS OF TYPE 2 DIABETES MELLITUS. METHODS: THIS RANDOMIZED PARALLEL STUDY WAS CARRIED OUT IN MEDICAL COLLEGE TRIVANDRUM, KERALA, INDIA. HUNDRED TYPE 2 DIABETICS WITH DYSLIPIDEMIA WERE RANDOMIZED INTO CONTROL AND YOGA GROUPS. THE CONTROL GROUP WAS PRESCRIBED ORAL HYPOGLYCEMIC DRUGS. THE YOGA GROUP PRACTICED YOGA DAILY FOR 1 H DURATION ALONG WITH ORAL HYPOGLYCEMIC DRUGS FOR 3 MONTHS. THE LIPID PROFILES OF BOTH THE GROUPS WERE COMPARED AT THE START AND AT THE END OF 3 MONTHS. RESULTS: AFTER INTERVENTION WITH YOGA FOR A PERIOD OF 3 MONTHS THE STUDY GROUP SHOWED A DECREASE IN TOTAL CHOLESTEROL, TRIGLYCERIDES AND LDL, WITH AN IMPROVEMENT IN HDL. CONCLUSION: YOGA, BEING A LIFESTYLE INCORPORATING EXERCISE AND STRESS MANAGEMENT TRAINING, TARGETS THE ELEVATED LIPID LEVELS IN PATIENTS WITH DIABETES THROUGH INTEGRATED APPROACHES. 2013 9 1378 33 IMPACT OF INDIVIDUALIZED YOGA THERAPY ON PERCEIVED QUALITY OF LIFE PERFORMANCE ON COGNITIVE TASKS AND DEPRESSION AMONG TYPE II DIABETIC PATIENTS. CONTEXT: AN INDIVIDUALIZED APPROACH OF PROVIDING YOGA SUPPORT CAN ADDRESS MANY OF THE DISEASE-RELATED CONCERNS INDICATED IN THE MANAGEMENT OF DIABETES, SPECIFICALLY THE IMPACT ON OTHER LIFE ACTIVITIES AND LONG-TERM FUNCTIONAL WELLBEING. AIM: TO ANALYZE THE ROLE OF REGULAR YOGA PRACTICE AS A SELF-MANAGEMENT APPROACH TO ACHIEVE GLYCEMIC CONTROL AND PSYCHOLOGICAL WELLBEING IN TYPE II DIABETIC PATIENTS. METHODS: NINETY-ONE SUBJECTS OF BOTH SEXES RESPONDED TO THE ANNOUNCEMENT AND CONSENTED TO PARTICIPATE IN THE STUDY. THIS WAS A SINGLE GROUP, BEFORE AND AFTER YOGA EVALUATION WITHOUT CONTROL COMPARISON. THE FASTING AND POSTPRANDIAL BLOOD SUGAR, GLYCOSYLATED HEMOGLOBIN (HBA1C), COGNITIVE TASKS, DEPRESSION, COGNITIVE FAILURE, AND DIABETIC-RELATED QUALITY OF LIFE (QOL) WERE MEASURED AS PRETEST. THE SUBJECTS UNDERWENT ONE-TO-ONE INDIVIDUALIZED YOGA THERAPY SESSIONS, WHICH INCLUDED 12 SUPERVISED SESSIONS SPREAD OVER A 3-MONTH PERIOD. THE POSTTEST DATA WERE ANALYZED USING PAIRED T-TEST AND WILCOXON PAIRED RANK TEST. RESULTS: SHOWED SIGNIFICANT REDUCTION IN FASTING BLOOD SUGAR. QOL OF THE DIABETIC PATIENTS HAD IMPROVED SIGNIFICANTLY. THERE WAS A SIGNIFICANT REDUCTION IN THE FREQUENCY (MEAN DIFFERENCE OF 7.58, P > 0.01) OF DEPRESSIVE SYMPTOMS AND INTENSITY OF DEPRESSION (MEAN DIFFERENCE 1.66, P > 0.05). CONCENTRATION AND ATTENTION SPAN IMPROVED SIGNIFICANTLY AND MEAN DISCREPANCY SCORE REDUCED (MEAN DIFFERENCE 3.42, P > 0.01). THERE WERE NO MARKED CHANGES IN THE POSTPRANDIAL BLOOD SUGAR AND HBA1C. CONCLUSION: YOGA PRACTICE ENHANCES THE SUBJECTIVE WELLBEING, QOL, IMPROVES MOOD AND CONCENTRATION, AND FACILITATES ACHIEVEMENT OF ADEQUATE GLYCEMIC CONTROL AMONG TYPE II DIABETIC PATIENTS. 2016 10 1102 33 EFFECTS OF YOGA TRAINING ON BODY COMPOSITION AND OXIDANT-ANTIOXIDANT STATUS AMONG HEALTHY MALE. BACKGROUND: THE STRESSFUL CONDITION MAY CAUSE OXIDATIVE STRESS, WHICH IS RESPONSIBLE FOR VARIOUS DISEASES. AIMS: THE PRESENT STUDY WAS DESIGNED TO FIND OUT WHETHER YOGA HAS IMPACT ON THE REDUCTION OF OXIDATIVE STRESS. METHODS: FOR THE PRESENT STUDY, 95 (N = 95) HEALTHY MALE VOLUNTEERS WITHIN THE AGE GROUP OF 18-24 YEARS WERE INCLUDED, 35 (N = 35) VOLUNTEERS WERE EXCLUDED. THE REMAINING 60 (N = 60) VOLUNTEERS WERE RANDOMLY DIVIDED INTO TWO GROUPS: (A) YOGA GROUP (N = 30) AND (B) CONTROL GROUP (N = 30). YOGA TRAINING WAS GIVEN FOR 60 MIN PER DAY, 6 DAYS PER WEEK FOR 12 WEEKS IN THE YOGA GROUP, WITH NO YOGA TRAINING IN CONTROL GROUP. ASSESSMENT OF BODY COMPOSITION AND OXIDANT-ANTIOXIDANT STATUS WERE PERFORMED IN BOTH THE GROUPS AT BASELINE, BEFORE YOGA TRAINING (0 WEEK) AND AFTER (12 WEEKS) OF THE TRAINING. RESULTS: SIGNIFICANT REDUCTION (P < 0.001) IN THE PERCENTAGE OF BODY FAT AND MALONDIALDEHYDE; SIGNIFICANT ELEVATION (P < 0.001) IN SUPEROXIDE DISMUTASE, CATALASE, REDUCED GLUTATHIONE AND ASCORBIC ACID LEVELS WERE NOTED IN THE YOGA GROUP AFTER 12 WEEKS WHEN COMPARED TO BASELINE DATA (0 WEEK). HOWEVER, THERE WAS NO SIGNIFICANT DIFFERENCE IN HEIGHT, WEIGHT, BODY MASS INDEX, BODY SURFACE AREA AND LEAN BODY MASS AMONG THE YOGA GROUP AFTER 12 WEEKS WHEN COMPARED TO BASELINE DATA. THESE CHANGES MIGHT BE DUE TO YOGA TRAINING. CONCLUSIONS: REGULAR YOGA PRACTICE REDUCES BODY FAT AND OXIDATIVE STRESS. YOGA TRAINING MAY BE HELPFUL TO REDUCE THE CHANCE OF OCCURRENCE OF VARIOUS DISEASES AND HELPS TO MAINTAIN NORMAL HEALTHY LIFESTYLE. 2018 11 926 32 EFFECTIVENESS OF YOGA LIFESTYLE ON LIPID METABOLISM IN A VULNERABLE POPULATION-A COMMUNITY BASED MULTICENTER RANDOMIZED CONTROLLED TRIAL. BACKGROUND: DYSLIPIDEMIA POSES A HIGH RISK FOR CARDIOVASCULAR DISEASE AND STROKE IN TYPE 2 DIABETES (T2DM). THERE ARE NO STUDIES ON THE IMPACT OF A VALIDATED INTEGRATED YOGA LIFESTYLE PROTOCOL ON LIPID PROFILES IN A HIGH-RISK DIABETES POPULATION. METHODS: HERE, WE REPORT THE RESULTS OF LIPID PROFILE VALUES OF 11,254 (YOGA 5932 AND CONTROL 5322) ADULTS (20-70 YEARS) OF BOTH GENDERS WITH HIGH RISK (>/=60 ON INDIAN DIABETES RISK SCORE) FOR DIABETES FROM A NATIONWIDE RURAL AND URBAN COMMUNITY-BASED TWO GROUP (YOGA AND CONVENTIONAL MANAGEMENT) CLUSTER RANDOMIZED CONTROLLED TRIAL. THE YOGA GROUP PRACTICED A VALIDATED INTEGRATED YOGA LIFESTYLE PROTOCOL (DYP) IN NINE DAY CAMPS FOLLOWED BY DAILY ONE-HOUR PRACTICE. BIOCHEMICAL PROFILING INCLUDED GLYCATED HEMOGLOBIN AND LIPID PROFILES BEFORE AND AFTER THREE MONTHS. RESULTS: THERE WAS A SIGNIFICANT DIFFERENCE BETWEEN GROUPS (P < 0.001 ANCOVA) WITH IMPROVED SERUM TOTAL CHOLESTEROL, TRIGLYCERIDES, LOW-DENSITY LIPOPROTEIN, AND HIGH-DENSITY LIPOPROTEIN IN THE YOGA GROUP COMPARED TO THE CONTROL GROUP. FURTHER, THE REGULATORY EFFECT OF YOGA WAS NOTED WITH A SIGNIFICANT DECREASE OR INCREASE IN THOSE WITH HIGH OR LOW VALUES OF LIPIDS, RESPECTIVELY, WITH MARGINAL OR NO CHANGE IN THOSE WITHIN THE NORMAL RANGE. CONCLUSION: YOGA LIFESTYLE IMPROVES AND REGULATES (LOWERED IF HIGH, INCREASED IF LOW) THE BLOOD LIPID LEVELS IN BOTH GENDERS OF PREDIABETIC AND DIABETIC INDIVIDUALS IN BOTH RURAL AND URBAN INDIAN COMMUNITIES. 2021 12 1402 38 IMPACT OF YOGA ON BLOOD PRESSURE AND QUALITY OF LIFE IN PATIENTS WITH HYPERTENSION - A CONTROLLED TRIAL IN PRIMARY CARE, MATCHED FOR SYSTOLIC BLOOD PRESSURE. BACKGROUND: MEDICAL TREATMENT OF HYPERTENSION IS NOT ALWAYS SUFFICIENT TO ACHIEVE BLOOD PRESSURE CONTROL. DESPITE THIS, PREVIOUS STUDIES ON SUPPLEMENTARY THERAPIES, SUCH AS YOGA, ARE RELATIVELY FEW. WE INVESTIGATED THE EFFECTS OF TWO YOGA INTERVENTIONS ON BLOOD PRESSURE AND QUALITY OF LIFE IN PATIENTS IN PRIMARY HEALTH CARE DIAGNOSED WITH HYPERTENSION. METHODS: ADULT PATIENTS (AGE 20-80 YEARS) WITH DIAGNOSED HYPERTENSION WERE IDENTIFIED BY AN ELECTRONIC CHART SEARCH AT A PRIMARY HEALTH CARE CENTER IN SOUTHERN SWEDEN. IN TOTAL, 83 SUBJECTS WITH BLOOD PRESSURE VALUES OF 120-179//= 23 TO <35 KG/M [2] PER ASIAN CUT-OFF VALUES] INDIVIDUALS WERE ENROLLED, AND RECEIVED DIRECTLY SUPERVISED INTERVENTION FOR 10 DAYS. THEREAFTER, THEY WERE ADVISED TO FOLLOW THIS YOGA-BASED LIFESTYLE AT HOME FOR ONE MONTH, AND WERE REASSESSED FOR STUDY VARIABLES AT DAY 30. RESULTS: THERE WAS A REDUCTION FROM BASELINE TO DAY 10 IN WEIGHT ( P <0.001), BMI ( P <0.001), WAIST/HIP-RATIO ( P <0.05), BLOOD GLUCOSE ( P <0.01), AND A SIGNIFICANT IMPROVEMENT IN LIPID PROFILE. THERE WAS A DECREASE IN MEDIAN FASTING INSULIN ( P <0.05), HOMEOSTATIC MODEL ASSESSMENT-INSULIN RESISTANCE ( P <0.01), AND IL-6 ( PP <0.05). A NON-SIGNIFICANT INCREASE IN 25-OH-VITAMIN D, AND A DECREASE IN NEOPTERIN AND VASPIN WERE OBSERVED. TWENTY SUBJECTS RETURNED FOR FOLLOW UP ASSESSMENTS. AT DAY 30, WEIGHT LOSS WAS SUSTAINED WHILE SYSTOLIC BLOOD PRESSURE ALSO SHOWED REDUCTION ( P <0.05). CHANGES IN VITAMIN D LEVELS WERE SIGNIFICANTLY AND NEGATIVELY CORRELATED WITH CHANGES IN WEIGHT, BMI AND FASTING BLOOD GLUCOSE, AND POSITIVELY WITH CHANGE IN HIGH DENSITY LIPOPROTEIN. CHANGES IN BODY WEIGHT AND BMI SIGNIFICANTLY AND POSITIVELY CORRELATED WITH INSULIN. CHANGES IN IL-6 LEVELS POSITIVELY AND SIGNIFICANTLY CORRELATED WITH CHANGE IN NEOPTERIN LEVELS. INTERPRETATION & CONCLUSIONS: THE FINDINGS SHOWED THAT IL-6, VITAMIN D, AND DIABETES RISK FACTORS WERE FAVOURABLY MODIFIED BY A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN OBESITY. THIS STUDY ALSO HIGHLIGHTED THE CHALLENGES IN COMPLIANCE ASSOCIATED WITH THE FOLLOW UP OF SUBJECTS FOLLOWING AN AGGRESSIVE SUPERVISED INTERVENTION OF 10 DAYS. 2015 14 823 36 EFFECT OF YOGA ON GLUCOSE CONTROL AND QUALITY OF LIFE IN PATIENTS OF PREDIABETES. OBJECTIVE: THE OBJECTIVE OF THIS STUDY WAS TO EVALUATE EFFECT OF YOGA ON FASTING PLASMA GLUCOSE (FPG), POSTPRANDIAL PLASMA GLUCOSE, AND HEMOGLOBIN A1C (HBA1C) AND ALSO ON QUALITY OF LIFE (QOL). RESEARCH DESIGN AND METHODS: THIS WAS A COHORT STUDY IN WHICH 100 DIAGNOSED CASES OF PREDIABETES WERE RECRUITED FOR DOING SPECIFIC YOGA, AND THEY THEMSELVES ACT AS CONTROL FOR THE STUDY. THE MEASUREMENT AND COMPARISON OF FPG, PRANDIAL PLASMA GLUCOSE (PPG), AND HBA1C WERE DONE AT THREE DIFFERENT TIME INTERVALS, THAT IS, BASELINE, 3 MONTHS, AND AT 6 MONTHS. THE ASSESSMENT OF QOL WAS DONE USING SF-36 SCALE. RESULTS: ONE HUNDRED PREDIABETIC CASES WERE SELECTED FOR THE STUDY IN WHICH IMPAIRED FASTING GLUCOSE (IFG) WAS PRESENT MORE IN YOUNGER POPULATION COMPARED TO IMPAIRED GLUCOSE TOLERANCE (IGT) AND IFG PLUS IGT BOTH OF WHICH ARE MORE PREVALENT IN MIDDLE AGE GROUP. THE YOGA THERAPY WAS FOUND TO HAVE FAVORABLE EFFECT ON FPG, PPG, AND HBA1C ALONG WITH VARIOUS ANTHROPOMETRY MEASURES STUDIED IN THIS STUDY. AFTER ADJUSTING CORRELATION COEFFICIENT FOR VARIOUS ANTHROPOMETRY MEASURES, YOGA WAS FOUND TO BE EFFECTIVE FOR CONTROLLING GLYCEMIC PARAMETERS IN PREDIABETICS. CONCLUSIONS: YOGA IS A TYPE OF EXERCISE KNOWN TO IMPROVE GLYCEMIC CONTROL BY CHANGING ANTHROPOMETRY MEASURES, BUT OUR STUDY AIDS IN KNOWLEDGE ABOUT THE BENEFICIAL EFFECT BEYOND THIS KNOWN FACT THROUGH OTHER MECHANISMS YET TO BE EXPLORED. 2021 15 876 39 EFFECT OF YOGA THERAPY ON REACTION TIME, BIOCHEMICAL PARAMETERS AND WELLNESS SCORE OF PERI AND POST-MENOPAUSAL DIABETIC PATIENTS. BACKGROUND: YOGIC PRACTICES MAY AID IN THE PREVENTION AND MANAGEMENT OF DIABETES MELLITUS (DM) AND REDUCE CARDIOVASCULAR COMPLICATIONS IN THE POPULATION. THE PRESENT STUDY HAS BEEN UNDERTAKEN TO EVALUATE THE EFFECT OF YOGA THERAPY ON REACTION TIME, BIOCHEMICAL PARAMETERS AND WELLNESS SCORE OF PERI AND POST-MENOPAUSAL DIABETIC PATIENTS. MATERIALS AND METHODS: 15 PERI AND POST-MENOPAUSAL PATIENTS RECEIVING STANDARD MEDICAL TREATMENT FOR TYPE 2 DM WERE RECRUITED AND REACTION TIME AND BIOCHEMICAL INVESTIGATIONS WERE DONE BEFORE AND AFTER A COMPREHENSIVE YOGA THERAPY PROGRAM COMPRISING OF THREE TIMES A WEEK SESSIONS FOR SIX WEEKS. A POST-INTERVENTION, RETROSPECTIVE WELLNESS QUESTIONNAIRE COMPILED BY ACYTER WAS USED TO EVALUATE THE COMPARATIVE FEELINGS OF THE PATIENTS AFTER THE THERAPY PROGRAM. RESULTS: YOGA TRAINING REDUCED AUDITORY REACTION TIME (ART) FROM RIGHT AS WELL AS LEFT HAND, THE DECREASE BEING STATISTICALLY SIGNIFICANT (P<0.05) FOR ART FROM THE RIGHT HAND. THERE WAS A SIGNIFICANT (P<0.01) DECREASE IN FASTING AND POSTPRANDIAL BLOOD GLUCOSE LEVELS AS WELL AS LOW DENSITY LIPOPROTEIN. THE DECREASE IN TOTAL CHOLESTEROL, TRIGLYCERIDES, AND VERY LOW DENSITY LIPOPROTEIN AND INCREASE IN HIGH DENSITY LIPOPROTEIN WAS ALSO STATISTICALLY SIGNIFICANT (P<0.05). ALL THE LIPID RATIOS SHOWED DESIRABLE IMPROVEMENT WITH A DECREASE (P<0.01) OF TC/HDL AND LDL/HDL RATIOS AND INCREASE (P<0.05) IN THE HDL/LDL RATIO. DISCUSSION OR CONCLUSION: SHORTENING OF RT IMPLIES AN IMPROVEMENT IN THE INFORMATION PROCESSING AND REFLEXES AND IS THE FIRST SUCH REPORT IN DIABETIC PATIENTS. THIS HAS CLINICAL SIGNIFICANCE AND IS WORTH FURTHER EXPLORATION WITH WIDER, WELL CONTROLLED, RANDOMIZED STUDIES IN THE DIABETIC POPULATION. CHANGES IN BLOOD GLUCOSE LEVELS MAY BE DUE TO IMPROVED INSULIN SENSITIVITY, DECLINE IN INSULIN RESISTANCE AND INCREASED SENSITIVITY OF THE PANCREATIC B CELLS TO GLUCOSE SIGNALS. YOGA IMPROVED THE 'HEART FRIENDLY' STATUS OF LIPID PROFILE IN OUR SUBJECTS AND AS OUR PARTICIPANTS WERE PERI AND POST-MENOPAUSAL, THE DECREASE IN CARDIOVASCULAR RISK PROFILE IS OF GREATER SIGNIFICANCE. A COMPREHENSIVE YOGA THERAPY PROGRAM HAS THE POTENTIAL TO ENHANCE THE BENEFICIAL EFFECTS OF STANDARD MEDICAL MANAGEMENT OF DIABETES MELLITUS AND CAN BE USED AS AN EFFECTIVE COMPLEMENTARY OR INTEGRATIVE THERAPY PROGRAM. 2012 16 1849 37 QUASI PROSPECTIVE COMPARATIVE STUDY ON EFFECT OF YOGA AMONG PREDIABETICS ON PROGRESSION OF CARDIOVASCULAR RISK FACTORS. INTRODUCTION: PREDIABETIC PATIENTS HAVE HIGHER RISK FOR CARDIOVASCULAR DISEASES, WHICH FURTHER INCREASES THE RATE OF MORTALITY. REASON FOR THE RATE OF INCREASE MAY BE LACK OF OBSERVATION, FOLLOW-UP PROGRAMS, AND SELF-AWARENESS ABOUT THE CONDITIONS OF DISEASE. LIFESTYLE INTERVENTIONS SUCH AS YOGA CAN PROVE TO BE A BENEFICIAL NONPHARMACOLOGIC INTERVENTION IN PREVENTING PROGRESSION OF PREDIABETES TO TYPE 2 DIABETES. THIS STUDY HIGHLIGHTS IMPORTANCE OF SHORT-TERM INTERVENTION, I.E., YOGA IN PREDIABETIC PATIENTS AND USE IT AS A TOOL FOR PRIMARY PREVENTION OF DIABETES. METHODS: THIS WAS AN INTERVENTIONAL STUDY AMONG ADULTS AGED 30-50 YEARS IN RUHS COLLEGE OF MEDICAL SCIENCES AND ASSOCIATED RUKMANI DEVI BENI PRASAD JAIPURIA HOSPITAL IN JAIPUR CITY. THE DESIGN OF STUDY WAS QUASI PROSPECTIVE COMPARATIVE STUDY. A TOTAL OF 102 PREDIABETIC PATIENTS OF AGE GROUP 30-50 YEARS WERE RECRUITED FROM JAIPURIA HOSPITAL. THESE WERE DIVIDED INTO TWO GROUPS: STUDY GROUP (GROUP A, N = 51) WERE ENGAGED IN YOGA SESSION AND CONTROL GROUP (B, N = 51) NOT PERFORMED ANY YOGA SESSION. RESULTS: YOGA INTERVENTION RESULTED IN A SIGNIFICANT DECLINE IN BLOOD GLUCOSE (P < 0.001), GLYCATED HEMOGLOBIN (P < 0.01), LIPID PROFILE CHOLESTEROL (P < 0.01), TRIGLYCERIDE (P < 0.01), AND LOW-DENSITY LIPOPROTEIN (P < 0.01), BUT HIGH-DENSITY LIPOPROTEIN (P < 0.02) AND VERY LOW-DENSITY LIPOPROTEIN INCREASE (P < 0.03) BUT NOT STATISTICALLY SIGNIFICANT RELATIVE TO THE CONTROL GROUP. CONCLUSION: SHORT-TERM YOGA INTERVENTION IS HELPFUL IN THE CONTROL OF GLYCEMIC PARAMETERS LIKE BLOOD GLUCOSE, GLYCATED HEMOGLOBIN AND LIPID PROFILE IN PREDIABETIC PATIENTS. THIS PRELIMINARY STUDY INDICATES THAT A YOGA PROGRAM WOULD BE A POSSIBLE RISK REDUCTION OPTION FOR ADULTS AT HIGH RISK FOR TYPE 2 DIABETES. IN ADDITION, YOGA HOLDS PROMISE AS AN APPROACH TO REDUCING CARDIOMETABOLIC RISK FACTORS AND INCREASING EXERCISE SELF-EFFICACY FOR PREDIABETICS PERFORMING YOGA. 2019 17 2834 37 YOGA'S EFFECT ON INFLAMMATORY BIOMARKERS AND METABOLIC RISK FACTORS IN A HIGH RISK POPULATION - A CONTROLLED TRIAL IN PRIMARY CARE. BACKGROUND: YOGA CAN REDUCE BLOOD PRESSURE AND HAS ALSO BEEN SUGGESTED TO REDUCE INFLAMMATORY BIOMARKERS AND METABOLIC RISK FACTORS FOR CARDIOVASCULAR DISEASES (CVDS). WE AIMED TO ASSESS THE BENEFIT OF TWO YOGA INTERVENTIONS ON INFLAMMATORY BIOMARKERS AND METABOLIC RISK FACTORS IN A HIGH RISK POPULATION IN PRIMARY CARE. METHODS: ADULT PATIENTS FROM A HEALTH CARE CENTER IN SWEDEN, WITH DIAGNOSED HYPERTENSION, WERE INVITED TO UNDERGO A BASELINE CHECK AT THE HEALTH CARE CENTER. BASELINE CHECK INCLUDED STANDARDIZED BLOOD PRESSURE MEASUREMENT, BMI AND WEIGHT CIRCUMFERENCE MEASUREMENTS, BLOOD SAMPLING (HS-CRP, IL-6, FP-GLUCOSE, HBA1C, CHOLESTEROL, TG, LDL AND HDL) AND A QUESTIONNAIRE ON SELF-RATED QUALITY OF LIFE (WHOQOL-BREF). THERE WERE THREE GROUPS: 1) YOGA CLASS WITH YOGA INSTRUCTOR; 2) YOGA AT HOME; AND 3) A CONTROL GROUP. IN TOTAL, 83 PATIENTS WERE INCLUDED AND MATCHED AT THE GROUP LEVEL FOR SYSTOLIC BLOOD PRESSURE. A MAJORITY OF THE PATIENTS (92 %) WERE ON ANTIHYPERTENSIVE MEDICATION, WHICH THEY WERE REQUESTED NOT TO CHANGE DURING THE STUDY. AFTER 12 WEEKS OF INTERVENTION, THE ASSESSMENTS WERE PERFORMED AGAIN. RESULTS: WE RECORDED NO EVIDENCE THAT YOGA ALTERED INFLAMMATORY BIOMARKERS OR METABOLIC RISK FACTORS IN OUR STUDY POPULATION. A TOTAL OF 49 PARTICIPANTS (59 %) MET THE CRITERIA FOR METABOLIC SYNDROME. CONCLUSION: THE YOGA INTERVENTIONS PERFORMED IN OUR STUDY DID NOT AFFECT INFLAMMATORY BIOMARKERS OR METABOLIC RISK FACTORS ASSOCIATED WITH CVD IN THE STUDY POPULATION OF PRIMARY CARE PATIENTS WITH HYPERTENSION. FURTHER RANDOMIZED TRIALS ARE NEEDED TO ELUCIDATE THE EFFECTS OF YOGA ON CVD RISK FACTORS IN THIS PARTICULAR GROUP. TRAIL REGISTRATION: NCT01302535 , FEBRUARY 22, 2011. 2015 18 796 41 EFFECT OF YOGA INTERVENTION ON BIOCHEMICAL, OXIDATIVE STRESS MARKERS, INFLAMMATORY MARKERS AND SLEEP QUALITY AMONG SUBJECTS WITH TYPE 2 DIABETES IN SOUTH INDIA: RESULTS FROM THE SATYAM PROJECT. AIMS: THE AIM OF THIS STUDY WAS TO INVESTIGATE THE EFFECT OF YOGA INTERVENTION ON THE BIOCHEMICAL, OXIDATIVE STRESS MARKERS AND INFLAMMATORY MARKERS AND SLEEP QUALITY AMONG SUBJECTS WITH TYPE 2 DIABETES. METHODS: SUBJECTS WITH TYPE 2 DIABETES ATTENDING A TERTIARY CARE CENTRE FOR DIABETES DURING FEB 2017 TO OCT 2019 IN CHENNAI, INDIA WERE RANDOMLY ASSIGNED TO TWO DIFFERENT GROUPS. GROUP1(NON-YOGA) (N = 150) WAS ADVISED ON SIMPLE PHYSICAL EXERCISES WHEREAS GROUP2(YOGA) (N = 150) WAS TRAINED AND ADVISED TO DO YOGASANAS WITH STATIC LOOSENING EXERCISES FOR 50 MIN FOR 5 DAYS IN A WEEK. BOTH THE GROUPS WERE FOLLOWED UP FOR A PERIOD OF 3 MONTHS. ANTHROPOMETRIC, BIOCHEMICAL, OXIDATIVE STRESS MARKERS, INFLAMMATORY MARKERS AND SLEEP QUALITY WERE ASSESSED AT BASELINE AND AFTER FOLLOW UP. RESULTS: THERE WAS A SIGNIFICANT REDUCTION IN BMI, BLOOD GLUCOSE LEVELS, HBA1C, LIPID LEVELS, IL6, TNFALPHA AND TBARS IN YOGA GROUP AS COMPARED TO NON-YOGA GROUP. THERE WAS MARKED IMPROVEMENT IN THE LEVELS OF ADIPONECTIN, PTGIS AND SLEEP QUALITY AMONG SUBJECTS PRACTISING YOGASANAS. CONCLUSION: REGULAR PRACTICE OF YOGASANAS IMPROVED GLYCAEMIC CONTROL, OXIDATIVE STRESS, INFLAMMATORY RESPONSE AND SLEEP QUALITY AMONG SUBJECTS WITH TYPE 2 DIABETES. HENCE, YOGASANAS CAN BE USED AS AN ADJUVANT THERAPY FOR MANAGING TYPE 2 DIABETES. 2021 19 772 37 EFFECT OF YOGA AND EXERCISE ON GLYCEMIC CONTROL AND PSYCHOSOCIAL PARAMETERS IN TYPE 2 DIABETES MELLITUS: A RANDOMIZED CONTROLLED STUDY. CONTEXT BACKGROUND: TYPE 2 DIABETES HAS BEEN STRONGLY ASSOCIATED WITH PSYCHOSOCIAL FACTORS SUCH AS STRESS, ANXIETY, DEPRESSION, AND QUALITY OF LIFE (QOL). THERE IS NOT MUCH EVIDENCE WHETHER YOGA CAN IMPROVE THESE FACTORS AND MOTIVATE INDIVIDUALS TO ENGAGE IN ACTIVE LIFESTYLE. AIMS: THIS STUDY AIMS TO EVALUATE THE EFFECT OF YOGA AND EXERCISE OVER GLYCEMIC CONTROL, ANXIETY, DEPRESSION, EXERCISE SELF-EFFICACY (ESE), AND QOL AFTER 3-MONTH PROGRAM. METHODS: TWO HUNDRED AND TWENTY-SEVEN INDIVIDUALS WERE RANDOMLY ALLOCATED TO YOGA GROUP (YG) AND EXERCISE GROUP. YG PRACTICED YOGA FOR 2 WEEKS UNDER SUPERVISION AND THEN CARRIED OUT PRACTICE AT HOME FOR 3 MONTHS. THE EXERCISE GROUP PRACTICED 30 MIN OF BRISK WALKING FOR 5 DAYS A WEEK. RESULTS: ON COMPARISON AMONG THE GROUPS, IN YG, THERE WAS A MEAN CHANGE OF 0.47 IN GLYCATED HEMOGLOBIN WHICH WAS GREATER THAN MEAN REDUCTION OF 0.28 IN THE EXERCISE GROUP WITH P < 0.05. STATE ANXIETY REDUCED BY 7.8 AND TRAIT ANXIETY REDUCED BY 4.4 IN YG (P < 0.05) IN 3 MONTHS AS COMPARED TO NONSIGNIFICANT REDUCTIONS OF 3 AND 1 IN MEAN OF STATE AND TRAIT ANXIETY SCORES IN THE EXERCISE GROUP (P > 0.05). THERE WAS A STATISTICALLY SIGNIFICANT REDUCTION IN DEPRESSION SCORE IN BOTH THE GROUPS, 8.6 IN YOGA AND 4.0 IN EXERCISE, WHICH WAS GREATER IN YG. ESE IMPROVED BY 19.2 IN YG (P < 0.05), WHEREAS IT IMPROVED ONLY 2.2 IN THE EXERCISE GROUP (P > 0.05). QOL IMPROVED BY 23.7 IN YG AND 3.0 IN THE EXERCISE GROUP WHICH WAS NONSIGNIFICANT IN THE EXERCISE GROUP AS COMPARED TO YG. CONCLUSIONS: YOGA IS SUPERIOR TO EXERCISE ALONE AS A LIFESTYLE MODIFICATION PROGRAM IN IMPROVING GLYCEMIC CONTROL, ANXIETY, DEPRESSION, AND QOL AS WELL AS ESE. 2020 20 2353 33 UTILIZATION OF 3-MONTH YOGA PROGRAM FOR ADULTS AT HIGH RISK FOR TYPE 2 DIABETES: A PILOT STUDY. VARIOUS MODES OF PHYSICAL ACTIVITY, COMBINED WITH DIETING, HAVE BEEN WIDELY RECOMMENDED TO PREVENT OR DELAY TYPE 2 DIABETES. AMONG THESE, YOGA HOLDS PROMISE FOR REDUCING RISK FACTORS FOR TYPE 2 DIABETES BY PROMOTING WEIGHT LOSS, IMPROVING GLUCOSE LEVELS AND REDUCING BLOOD PRESSURE AND LIPID LEVELS. THIS PILOT STUDY AIMED TO ASSESS THE FEASIBILITY OF IMPLEMENTING A 12-WEEK YOGA PROGRAM AMONG ADULTS AT HIGH RISK FOR TYPE 2 DIABETES. TWENTY-THREE ADULTS (19 WHITES AND 4 NON-WHITES) WERE RANDOMLY ASSIGNED TO THE YOGA INTERVENTION GROUP OR THE EDUCATIONAL GROUP. THE YOGA GROUP PARTICIPATED IN A 3-MONTH YOGA INTERVENTION WITH SESSIONS TWICE PER WEEK AND THE EDUCATIONAL GROUP RECEIVED GENERAL HEALTH EDUCATIONAL MATERIALS EVERY 2 WEEKS. ALL PARTICIPANTS COMPLETED QUESTIONNAIRES AND HAD BLOOD TESTS AT BASELINE AND AT THE END OF 3 MONTHS. EFFECT SIZES WERE REPORTED TO SUMMARIZE THE EFFICACY OF THE INTERVENTION. ALL PARTICIPANTS ASSIGNED TO THE YOGA INTERVENTION COMPLETED THE YOGA PROGRAM WITHOUT COMPLICATION AND EXPRESSED HIGH SATISFACTION WITH THE PROGRAM (99.2%). THEIR YOGA SESSION ATTENDANCE RANGED FROM 58.3 TO 100%. COMPARED WITH THE EDUCATION GROUP, THE YOGA GROUP EXPERIENCED IMPROVEMENTS IN WEIGHT, BLOOD PRESSURE, INSULIN, TRIGLYCERIDES AND EXERCISE SELF-EFFICACY INDICATED BY SMALL TO LARGE EFFECT SIZES. THIS PRELIMINARY STUDY INDICATES THAT A YOGA PROGRAM WOULD BE A POSSIBLE RISK REDUCTION OPTION FOR ADULTS AT HIGH RISK FOR TYPE 2 DIABETES. IN ADDITION, YOGA HOLDS PROMISE AS AN APPROACH TO REDUCING CARDIOMETABOLIC RISK FACTORS AND INCREASING EXERCISE SELF-EFFICACY FOR THIS GROUP. 2011